LPCN - Lipocine Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - LPCN (1535955)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
6 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2023-05-25
LPCNPatel Mahesh V.CEO, PresP - Purchase$5.03+8,706107,418+9%+$43,791
2023-03-24
LPCNPatel Mahesh V.CEO, PresP - Purchase$0.32+150,0001,678,090+10%+$48,000
2023-03-20
LPCNOno Richard DanaDirP - Purchase$0.34+4,00014,125+40%+$1,360
2023-03-17
LPCNPatel Mahesh V.CEO, PresP - Purchase$0.33+50,0001,528,090+3%+$16,500
2022-11-22
LPCNPapapetropoulos SpyrosDirP - Purchase$0.47+21,73921,739New+$10,217
2022-11-14
LPCNPatel Mahesh V.CEO, PresP - Purchase$0.39+75,0001,478,090+5%+$29,250

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top